Skip to main content
CELADON PHARMACEUTICALS PLC logo

CELADON PHARMACEUTICALS PLC — Investor Relations & Filings

Ticker · CEL ISIN · GB00BDQYGP38 LEI · 213800YXCATORT475807 IL Manufacturing
Open in API
Filings indexed 121 across all filing types
Latest filing 2025-01-31 Capital/Financing Update
Country GB United Kingdom
Listing IL CEL

About CELADON PHARMACEUTICALS PLC

https://celadonpharma.co.uk/

Celadon Pharmaceuticals PLC is a vertically integrated pharmaceutical company focused on the research, cultivation, manufacturing, and supply of cannabinoid-based medicines. The company operates a licensed, 100,000 sq ft facility with EU-GMP certification for the indoor, hydroponic cultivation of high-THC cannabis and the extraction of cannabinoid Active Pharmaceutical Ingredients (API). Its primary focus is the chronic pain market, and it is conducting an MHRA conditionally approved clinical trial to generate data supporting the use of its medicines for this condition. Additionally, Celadon has an in-house research and development program focused on intellectual property generation and is involved in developing a licensed cannabinoid treatment for Autism Spectrum Disorder through a biopharma partnership.

Recent filings

Filing Released Lang Actions
Finance Update
Capital/Financing Update Classification · 99% confidence The document is identified by the RNS Number (3658V) and explicitly states it is an announcement from Celadon Pharmaceuticals Plc, providing a 'Finance Update'. It discusses the status of a credit facility draw down, working capital projections, ongoing financing discussions, and a change in registered office address. This type of brief, material update that is not a full financial report (like 10-K or IR) and is disseminated via the RNS system (London Stock Exchange's news service) fits best under the general 'Regulatory Filings' category, as it is a mandatory disclosure of material, non-public information, or it could be classified as a Capital/Financing Update (CAP) due to the focus on the credit facility. However, since it is explicitly distributed via RNS and contains miscellaneous corporate updates (office move) alongside the finance update, RNS (Regulatory Filings) is the most appropriate general classification for this type of market news release, especially given the explicit mention of RNS at the end. Given the options, RNS is the most encompassing category for a general regulatory news service release that isn't a specific report type like ER or IR.
2025-01-31 English
Update on Strategic Collaboration
Regulatory Filings Classification · 100% confidence The document begins with an 'RNS Number' and is dated 16 January 2025. It contains an update on a strategic collaboration and mentions that the information constitutes 'inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014'. The closing section explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This structure and explicit mention of RNS strongly indicate a general regulatory announcement or news service release that does not fit a more specific category like 10-K, ER, or DIV. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length (5824 chars) is substantial enough that it is not just a brief announcement of a report, but the content itself is a business update.
2025-01-16 English
Funding Update
Capital/Financing Update Classification · 99% confidence The document begins with an 'RNS Number' and is dated 02 January 2025. It provides a 'Funding Update' regarding the draw down of a Committed Credit Facility and confirms working capital sufficiency until March 2025. The text explicitly mentions that the information is provided by RNS, the news service of the London Stock Exchange, and that it contains 'inside information for the purposes of article 7 of the Market Abuse Regulation'. This structure and source strongly indicate a general regulatory announcement disseminated via the London Stock Exchange's Regulatory News Service (RNS). Since the content is a specific update (funding/working capital) that doesn't fit perfectly into the other specific categories (like 10-K, ER, or DIV), the most appropriate classification is the general regulatory announcement category, RNS.
2025-01-02 English
Finance Update
Capital/Financing Update Classification · 99% confidence The document is identified by the 'RNS Number' header and contains standard boilerplate language from RNS (the news service of the London Stock Exchange), explicitly stating, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content itself is a 'Finance Update' regarding credit facility payments and working capital, which is a type of corporate announcement. Since it is a direct announcement disseminated via the RNS system and does not fit neatly into specific financial report categories (like 10-K, IR, ER), the most appropriate classification is the general regulatory announcement category, RNS.
2024-12-20 English
Receipt of Subscription Proceeds
Share Issue/Capital Change Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange.' The content announces the 'Receipt of Subscription Proceeds' related to a previous share admission, which is a specific corporate action update. While it contains financial context, its primary function is a regulatory announcement of a corporate event. Since it is a specific, non-standard announcement (not 10-K, ER, or DIV) but is clearly a regulatory news service release, the most appropriate general category is 'Regulatory Filings' (RNS), as it fits the description of 'General regulatory announcements and fallback category for miscellaneous filings that do not neatly fit into other specific categories.' It is too specific for a general 'Regulatory Filings' fallback, but given the options, RNS is the best fit for an LSE RNS announcement.
2024-12-06 English
Update on Financial Position
Capital/Financing Update Classification · 99% confidence The document is identified by the RNS Number (5859M) and the header 'RNS Number'. It provides an 'Update on Financial Position' concerning cash flow, outstanding receivables, and ongoing discussions regarding credit facilities and alternative lending. This is a general, timely announcement regarding the company's financial status that does not fit the specific criteria for an Earnings Release (ER, which is usually quarterly highlights), an Interim Report (IR, which is comprehensive), or a Capital/Financing Update (CAP, which usually involves a specific transaction like an issuance or debt agreement). Since it is a general regulatory announcement disseminated via RNS (London Stock Exchange's news service), and it doesn't fit any other specific category, the most appropriate classification is the general Regulatory Filings category.
2024-11-18 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.